Solving society's problems with evidence is a work in progress, argues a must-read new book. The process is surprisingly new ...

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

May 7, 2026 expert reaction to clinical consensus statement on ultra-processed foods and cardiovascular diseases . A clinical consensus statement published in the European Heart J ...

A recent FDA 503A update in the U.S. should not be mistaken for a change in that picture. The FDA’s current safety page ...

A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that ...

Expanded Access Program (EAP) -- $10.2 million in net reimbursements and 122 patients enrolled across multiple territories, with France contributing a stable patient base and roughly $10 million net ...

Distinct Biology Driving Different Treatment Needs: Advances in genomic profiling reveal that pediatric leukemias are ...

HOW EASILY could a malicious person with no scientific expertise and an axe to grind create and spread a nasty pathogen? The bar is constantly being lowered. Advances in genetic sequencing have made ...

Anxiety is one of the most widespread mental health challenges of our time. Anxiety disorders are highly prevalent ...

Novavax ended the first quarter of 2026, with $818 million in cash and accounts receivables. We added $80 million of nondilutive cash in the first quarter of 2026, including a $30 million Pfizer ...

The number of people using medical cannabis in Israel is higher than ever, but growing evidence suggests that medical cannabis not only does not necessarily treat PTSD but may actually worsen it The ...